Academic Journal
Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC)
| العنوان: | Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC) |
|---|---|
| المؤلفون: | Hospital Infection Control Practices Advisory Committee (U.S.) |
| المساهمون: | Favero, Martin S., Gaynes, Robert P., Jarvis, William R. (William Robert) , 1948-, Shaw, J., Tablan, Ofelia C., Tenover, Fred C., Centers for Disease Control and Prevention (CDC), National Center for Infectious Diseases (U.S.) Hospital Infections Program. |
| بيانات النشر: | U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention (CDC) |
| المجموعة: | CDC Stacks (Centers for Disease Control and Prevention) |
| مصطلحات موضوعية: | Vancomycin, Vancomycin--Therapeutic use, Vancomycin--Therapeutic use--United States, Antibiotics, Anti-Bacterial Agents--phamacology, Cross Infection--drug therapy, Cross Infection--prevention & control, Drug Resistance, Microbial, Enterococcus--drug effects, Enterococcus--isolation & purification, Gram-Positive Bacterial Infections--drug therapy, Gram-Positive Bacterial Infections--prevention & control, Infection Control--standards, Vancomycin--phamacology, RA407.A1 M6 v.44 RR-12, HE 20.7009:Vol.44/RR-12 |
| جغرافية الموضوع: | United States |
| الوصف: | Since 1989, a rapid increase in the incidence of infection and colonization with vancomycin-resistant enterococci (VRE) has been reported by U.S. hospitals. This increase poses important problems, including a) the lack of available antimicrobial therapy for VRE infections, because most VRE are also resistant to drugs previously used to treat such infections (e.g., aminoglycosides and ampicillin), and b) the possibility that the vancomycin-resistant genes present in VRE can be transferred to other gram-positive microorganisms (e.g., Staphylococcus aureus). An increased risk for VRE infection and colonization has been associated with previous vancomycin and/or multiantimicrobial therapy, severe underlying disease or immunosuppression, and intraabdominal surgery. Because enterococci can be found in the normal gastrointestinal and female genital tracts, most enterococcal infections have been attributed to endogenous sources within the individual patient. However, recent reports of outbreaks and endemic infections caused by enterococci, including VRE, have indicated that patient-to-patient transmission of the microorganisms can occur either through direct contact or through indirect contact via a) the hands of personnel or b) contaminated patient-care equipment or environmental surfaces. This report presents recommendations of the Hospital Infection Control Practices Advisory Committee for preventing and controlling the spread of vancomycin resistance, with a special focus on VRE. Preventing and controlling the spread of vancomycin resistance will require coordinated, concerted efforts from all involved hospital departments and can be achieved only if each of the following elements is addressed: a) prudent vancomycin use by clinicians, b) education of hospital staff regarding the problem of vancomycin resistance, c) early detection and prompt reporting of vancomycin resistance in enterococci and other gram-positive microorganisms by the hospital microbiology laboratory, and d) immediate implementation of appropriate ... |
| نوع الوثيقة: | text |
| وصف الملف: | iv, 13 p.; 22 cm.; print |
| اللغة: | English |
| Relation: | http://stacks.cdc.gov/view/cdc/13487/ |
| الاتاحة: | http://stacks.cdc.gov/view/cdc/13487/ |
| رقم الانضمام: | edsbas.9709DB5F |
| قاعدة البيانات: | BASE |
| ResultId |
1 |
|---|---|
| Header |
edsbas BASE edsbas.9709DB5F 750 3 Academic Journal academicJournal 750 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.9709DB5F&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => http://stacks.cdc.gov/view/cdc/13487/# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC)
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Hospital+Infection+Control+Practices+Advisory+Committee+%28U%2ES%2E%29%22">Hospital Infection Control Practices Advisory Committee (U.S.)</searchLink> ) Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => Favero, Martin S.<br />Gaynes, Robert P.<br />Jarvis, William R. (William Robert) , 1948-<br />Shaw, J.<br />Tablan, Ofelia C.<br />Tenover, Fred C.<br />Centers for Disease Control and Prevention (CDC)<br />National Center for Infectious Diseases (U.S.) Hospital Infections Program. ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention (CDC) ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => CDC Stacks (Centers for Disease Control and Prevention) ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Vancomycin%22">Vancomycin</searchLink><br /><searchLink fieldCode="DE" term="%22Vancomycin--Therapeutic+use%22">Vancomycin--Therapeutic use</searchLink><br /><searchLink fieldCode="DE" term="%22Vancomycin--Therapeutic+use--United+States%22">Vancomycin--Therapeutic use--United States</searchLink><br /><searchLink fieldCode="DE" term="%22Antibiotics%22">Antibiotics</searchLink><br /><searchLink fieldCode="DE" term="%22Anti-Bacterial+Agents--phamacology%22">Anti-Bacterial Agents--phamacology</searchLink><br /><searchLink fieldCode="DE" term="%22Cross+Infection--drug+therapy%22">Cross Infection--drug therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Cross+Infection--prevention+%26+control%22">Cross Infection--prevention & control</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+Resistance%22">Drug Resistance</searchLink><br /><searchLink fieldCode="DE" term="%22Microbial%22">Microbial</searchLink><br /><searchLink fieldCode="DE" term="%22Enterococcus--drug+effects%22">Enterococcus--drug effects</searchLink><br /><searchLink fieldCode="DE" term="%22Enterococcus--isolation+%26+purification%22">Enterococcus--isolation & purification</searchLink><br /><searchLink fieldCode="DE" term="%22Gram-Positive+Bacterial+Infections--drug+therapy%22">Gram-Positive Bacterial Infections--drug therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Gram-Positive+Bacterial+Infections--prevention+%26+control%22">Gram-Positive Bacterial Infections--prevention & control</searchLink><br /><searchLink fieldCode="DE" term="%22Infection+Control--standards%22">Infection Control--standards</searchLink><br /><searchLink fieldCode="DE" term="%22Vancomycin--phamacology%22">Vancomycin--phamacology</searchLink><br /><searchLink fieldCode="DE" term="%22RA407%2EA1+M6+v%2E44+RR-12%22">RA407.A1 M6 v.44 RR-12</searchLink><br /><searchLink fieldCode="DE" term="%22HE+20%2E7009%3AVol%2E44%2FRR-12%22">HE 20.7009:Vol.44/RR-12</searchLink> ) Array ( [Name] => Subject [Label] => Subject Geographic [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22United+States%22">United States</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Since 1989, a rapid increase in the incidence of infection and colonization with vancomycin-resistant enterococci (VRE) has been reported by U.S. hospitals. This increase poses important problems, including a) the lack of available antimicrobial therapy for VRE infections, because most VRE are also resistant to drugs previously used to treat such infections (e.g., aminoglycosides and ampicillin), and b) the possibility that the vancomycin-resistant genes present in VRE can be transferred to other gram-positive microorganisms (e.g., Staphylococcus aureus). An increased risk for VRE infection and colonization has been associated with previous vancomycin and/or multiantimicrobial therapy, severe underlying disease or immunosuppression, and intraabdominal surgery. Because enterococci can be found in the normal gastrointestinal and female genital tracts, most enterococcal infections have been attributed to endogenous sources within the individual patient. However, recent reports of outbreaks and endemic infections caused by enterococci, including VRE, have indicated that patient-to-patient transmission of the microorganisms can occur either through direct contact or through indirect contact via a) the hands of personnel or b) contaminated patient-care equipment or environmental surfaces. This report presents recommendations of the Hospital Infection Control Practices Advisory Committee for preventing and controlling the spread of vancomycin resistance, with a special focus on VRE. Preventing and controlling the spread of vancomycin resistance will require coordinated, concerted efforts from all involved hospital departments and can be achieved only if each of the following elements is addressed: a) prudent vancomycin use by clinicians, b) education of hospital staff regarding the problem of vancomycin resistance, c) early detection and prompt reporting of vancomycin resistance in enterococci and other gram-positive microorganisms by the hospital microbiology laboratory, and d) immediate implementation of appropriate ... ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => text ) Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => iv, 13 p.; 22 cm.; print ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => http://stacks.cdc.gov/view/cdc/13487/ ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => http://stacks.cdc.gov/view/cdc/13487/ ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.9709DB5F ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => United States
[Type] => general
)
[1] => Array
(
[SubjectFull] => Vancomycin
[Type] => general
)
[2] => Array
(
[SubjectFull] => Vancomycin--Therapeutic use
[Type] => general
)
[3] => Array
(
[SubjectFull] => Vancomycin--Therapeutic use--United States
[Type] => general
)
[4] => Array
(
[SubjectFull] => Antibiotics
[Type] => general
)
[5] => Array
(
[SubjectFull] => Anti-Bacterial Agents--phamacology
[Type] => general
)
[6] => Array
(
[SubjectFull] => Cross Infection--drug therapy
[Type] => general
)
[7] => Array
(
[SubjectFull] => Cross Infection--prevention & control
[Type] => general
)
[8] => Array
(
[SubjectFull] => Drug Resistance
[Type] => general
)
[9] => Array
(
[SubjectFull] => Microbial
[Type] => general
)
[10] => Array
(
[SubjectFull] => Enterococcus--drug effects
[Type] => general
)
[11] => Array
(
[SubjectFull] => Enterococcus--isolation & purification
[Type] => general
)
[12] => Array
(
[SubjectFull] => Gram-Positive Bacterial Infections--drug therapy
[Type] => general
)
[13] => Array
(
[SubjectFull] => Gram-Positive Bacterial Infections--prevention & control
[Type] => general
)
[14] => Array
(
[SubjectFull] => Infection Control--standards
[Type] => general
)
[15] => Array
(
[SubjectFull] => Vancomycin--phamacology
[Type] => general
)
[16] => Array
(
[SubjectFull] => RA407.A1 M6 v.44 RR-12
[Type] => general
)
[17] => Array
(
[SubjectFull] => HE 20.7009:Vol.44/RR-12
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC)
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Hospital Infection Control Practices Advisory Committee (U.S.)
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Favero, Martin S.
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Gaynes, Robert P.
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Jarvis, William R. (William Robert) , 1948-
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Shaw, J.
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Tablan, Ofelia C.
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Tenover, Fred C.
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Centers for Disease Control and Prevention (CDC)
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => National Center for Infectious Diseases (U.S.) Hospital Infections Program.
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsbas.oa
)
)
)
)
)
)
)
|
| IllustrationInfo |